Farxiga (dapagliflozin) started life as a diabetes pill and has since become one of the most widely prescribed medicines in cardiology and kidney care, because the same drug protects the heart and slows kidney disease. That means three very different groups of people now take it: people with type 2 diabetes, people with heart failure, and people with chronic kidney disease, with or without diabetes. The side effects are largely the same for all of them, though a few apply mainly to people with diabetes, and they follow directly from how the medicine works, by making the kidneys pass sugar into the urine. This guide explains what the official label reports, which side effects are common and manageable, which are rare but serious, and what to do if Farxiga is not working for you, including research for each of the three conditions it treats.
Taking Farxiga for type 2 diabetes?
Studies are testing new options for blood sugar and weight in adults who are not on insulin or a GLP-1 medicine.
How Farxiga works
Farxiga belongs to the SGLT2 inhibitor family, alongside Jardiance (empagliflozin). It blocks a protein in the kidney that normally reabsorbs sugar, so excess glucose leaves the body in the urine. That lowers blood sugar without insulin, pulls some fluid and salt out with it, which eases strain on the heart, and lowers pressure inside the kidney's filters, which slows kidney damage. Nearly every side effect in the label traces back to one of those three actions: sugar in the urine feeds yeast and bacteria, fluid loss can cause dehydration and low blood pressure, and in people with diabetes the shift in metabolism can rarely trigger ketoacidosis.
The common side effects
In the pooled placebo controlled diabetes trials, the most common side effects were genital yeast infections, colds (nasopharyngitis), and urinary tract infections. Genital yeast infections were the standout: 8.4 percent of women on the 5 mg dose and 6.9 percent on 10 mg, compared with 1.5 percent on placebo, with lower rates in men. Urinary tract infections occurred in 5.7 and 4.3 percent versus 3.7 percent on placebo, and increased urination in about 3 to 4 percent versus 1.7 percent. People who had yeast infections before were more likely to get them again. Serious genital infections were rare, under 0.1 percent. Back pain, nausea, and constipation appeared at low rates. In the heart failure and kidney disease trials, which included many people without diabetes, no new side effects emerged, and the overall pattern was similar.
The side effects that need prompt attention
Ketoacidosis. A dangerous build up of acids in the blood that can occur in people with diabetes even when blood sugar is only mildly raised, sometimes around surgery, severe illness, or very low carbohydrate intake. Nausea, vomiting, abdominal pain, tiredness, and trouble breathing are the warning signs. It is uncommon in type 2 diabetes but the label advises stopping Farxiga at least 3 days before major surgery, if possible, and in other situations known to raise the risk; your doctor manages this.
Dehydration and low blood pressure. Because Farxiga pulls fluid out, it can cause dizziness on standing, especially in older adults, people on diuretics or blood pressure medicines, and people with reduced kidney function. The label notes it can cause a small, usually temporary rise in creatinine when started. Drinking normally and reporting dizziness are the practical steps.
Serious urinary and genital infections. Kidney infections and urosepsis have been reported, and very rarely a severe infection of the tissue around the genitals called Fournier's gangrene. Pain, redness, or swelling in the genital area with fever needs same day care.
Low blood sugar with insulin or sulfonylureas. Farxiga alone rarely causes low blood sugar, but it can add to the effect of those medicines, which may need adjusting.
Allergic reactions. Rare, including swelling and hives.
Lowering the risk of the side effects
Good genital hygiene and prompt treatment of a yeast infection, which usually responds to standard over the counter or prescription antifungals without stopping Farxiga, keep the most common problem manageable. Staying hydrated, especially in hot weather or during illness, reduces dizziness and kidney strain. Telling your surgeon or dentist you take Farxiga matters, because it is usually paused before procedures. And because it increases urination at first, many people prefer to take it in the morning.
Farxiga for heart failure and kidney disease
Farxiga is approved to reduce the risk of cardiovascular death and heart failure hospitalization in adults with heart failure, and to reduce the risk of worsening kidney function, kidney failure, cardiovascular death, and heart failure hospitalization in adults with chronic kidney disease, whether or not they have diabetes. Those approvals came from large outcome trials, including one in more than 4,000 people with chronic kidney disease. People taking it for these reasons are often also on several other heart or kidney medicines, which is where the dizziness and creatinine effects deserve attention when the medicine is started. Our guides cover heart failure treatment and chronic kidney disease treatment in detail.
If Farxiga is not right for you
Some people cannot tolerate recurrent infections, some cannot take it because of kidney function or a history of ketoacidosis, and some simply do not reach their goals on it. Do not stop it on your own, because for heart failure and kidney disease it is protecting organs even when you feel nothing. Alternatives depend on why you take it: for type 2 diabetes there are several other classes, covered in our guide to type 2 diabetes treatment options; for heart failure, the other pillars of treatment; for kidney disease, newer medicines added in recent years. And for all three conditions, clinical studies are testing what comes next.
How to find a study
AllClinicalTrials.com lists studies recruiting across the US for all three conditions Farxiga treats, and you can filter by location before applying. Right now that includes a group of studies for adults with type 2 diabetes , a group of studies for adults with chronic kidney disease or protein in the urine, and a group of studies for adults with heart failure and other heart conditions who take medicine for them. The application takes about 5 minutes: you answer questions about your diagnosis, medicines, and recent test results, and if a study near you looks like a match, the research team contacts you. Nothing is decided until you have gone through informed consent, and participation is voluntary at every step.
Three things to have ready: the reason you take Farxiga, your current medicines and doses, and your most recent A1C, eGFR, or heart test results, whichever applies to you.
Common questions
What are the most common side effects of Farxiga? Genital yeast infections (about 7 to 8 percent of women in trials versus 1.5 percent on placebo), urinary tract infections, increased urination, and colds. Most are mild and treatable without stopping the medicine.
What are the serious side effects of Farxiga? Ketoacidosis in people with diabetes, dehydration with low blood pressure, kidney infections and very rarely Fournier's gangrene, low blood sugar when combined with insulin or sulfonylureas, and allergic reactions. All are uncommon, and each has warning signs worth knowing.
Can Farxiga damage your kidneys? It is approved to protect the kidneys in chronic kidney disease. It can cause a small, usually temporary rise in creatinine when started and can contribute to kidney injury if you become dehydrated, which is why fluids matter.
Does Farxiga cause weight loss? Modest weight loss, a few pounds on average, is common because calories leave in the urine. It is not a weight loss medicine.
Can I take Farxiga if I do not have diabetes? Yes. It is approved for heart failure and chronic kidney disease in people with or without diabetes, and the side effect profile is similar.
What happens if I stop Farxiga? Blood sugar may rise in diabetes, and the heart and kidney protection stops. Talk to your doctor before stopping; it is usually paused only temporarily, around surgery or serious illness.
Do trial participants get paid? Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.